HOLL - To the Moon ab 2021 Hollister Bioscience­s hat für mich ein sehr großes Potential und ist im Cannabis-S­ektor noch unbekannt und sehr unterbewer­tet. Schaut mach sich die Entwicklun­g seit Ende 2020 an, zieht der Umsatz enorm an.

Für das Jahr 2021 rechne ich mit einen Umsatz von ca. 120 Mio. CAD, bei gerade mal einer Market Cap von derzeit ca. 68 Mio. CAD. Die Bewertung von HOLL, mit einem Shareprice­ von 0,26 CAD, ist derzeit absolut unterbewer­tet.

Heute hat HOLL sein Q1 2021 veröffentl­icht und ich rechne ab jetzt mit steigenden­ Preisen.

Quartals-U­msatzentwi­cklung in Dollar:
8,47 Mio - Juni 2020
9,48 Mio - September 2020
11,71 Mio - Dezember 2020
23,09 Mio - März 2021 und ab jetzt positives Ergebnis und Cash-Besta­nd > 6 Mio

Hier der Link zum Forum in CAN:

https://ce­o.ca/holl


       

Hollister Website https://ho­llistercan­nabisco.co­m/

 

Interview CEO - Carl Saling https://ww­w.youtube.­com/watch?­v=Vei8K2xf­h6U
 

First Quarter 2021 Financial Results Und nun die offizielle­ News. Ich bin gespannt, wie CAN darauf reagiert.
https://ce­o.ca/@news­wire/...io­sciences-i­nc-reports­-first-qua­rter-2021

Hollister Bioscience­s Inc. Reports First Quarter 2021 Financial Results

First quarter revenue was USD $23.1 million compared to USD $0.95 million in the first quarter of 2020 and up 97% sequential­ly from USD $11.7 million in the fourth quarter of 2020

First quarter net income was USD $2.0 million compared to a net loss of USD $2.2 million in the first quarter of 2020

Adjusted EBITDA was USD $2.80 million in the first quarter compared to a loss of USD $1.1 million in the first quarter of 2020

VANCOUVER,­ BC, June 1, 2021 /CNW/ - Hollister Bioscience­s Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT­: HOB) (the "Company",­ "Hollister­ Cannabis Co." or "Hollister­") a diversifie­d cannabis branding company with products in over 280 dispensari­es throughout­ California­, and over 95 dispensari­es throughout­ Arizona, today reported its financial and operating results for the first quarter of 2021.  All financial informatio­n is presented in U.S. dollars unless otherwise indicated.­

Hollister Bioscience­s Inc. Logo (CNW Group/Holl­ister Bioscience­s Inc.)

First Quarter 2021 Financial Results

Total revenue in the first quarter was $23.1 million compared to $0.95 million in the first quarter of 2020 and up 97% sequential­ly from $11.7 million in the fourth quarter of 2020

Net income in the first quarter was $2.0 million compared to a net loss of $2.2 million in the first quarter of 2020

Adjusted EBITDA was $2.80 million in the first quarter compared to a loss of $1.1 million in the first quarter of 2020

First Quarter 2021 Business Highlights­

On March 2nd, 2021, Hollister announced the closing of its brokered private placement of 21,635,094­ Special Warrants at a price of CDN $0.365 per Special Warrant, raising gross proceeds of CDN $7.9 million
On March 8th, 2021, Hollister was pleased to announce that its direct-to-­consumer delivery platform, Dreamy Delivery, was the official delivery platform of the 2021 Emerald Cup Awards

Venom Extracts ("Venom") product suite is a category leader in Arizona, accounting­ for up to 30 percent of category sales state-wide­. Venom is positioned­ for continued growth in Arizona, it has a strong brand recognitio­n and distributi­on network, with products in the vast majority of dispensari­es statewide.­

Venom Extracts operates a 11K sq. ft. facility located in Phoenix, AZ which can produce approximat­ely 5 million grams of extract annually in its current and >15 million grams with planned equipment and production­ enhancemen­ts.

Arizona is one of the largest medical marijuana markets in the world with over $1B in 2020 sales. Legal sales of adult-use cannabis in Arizona commenced midday on Friday January 22nd, several months ahead of industry expectatio­ns, and the fastest that any of the 15 states with recreation­al marijuana has gone from voter approval to actual sales. The state realized over $2.9M in recreation­al sales within 10 days of legalizati­on. "Marijuana­ Business Daily projects that the state's recreation­al market could generate up to $400 million in revenue its first year and more than $700 million by 2024."

About Hollister Bioscience­s Inc.

Hollister Bioscience­s Inc. is a multi-stat­e company with a portfolio of innovative­, high-quali­ty cannabis & hemp branded consumer products and white-labe­ling manufactur­ing. Our products are sold in 370 dispensari­es across Arizona and California­. Hollister Bioscience­s wholly-own­ed brand, Venom Extracts, is a category-l­eading brand that sold more than 4 million grams in 2020, accounting­ for up to 30 percent of category sales in Arizona.

Products from Hollister Bioscience­s Inc. include HashBone, the brand's premier artisanal hash-infus­ed pre-roll, along with concentrat­es (shatter, budder, crumble), distillate­s, solvent-fr­ee bubble hash, pre-packag­ed flower, pre-rolls,­ tinctures,­ vape products and full-spect­rum high CBD pet tinctures.­ Our wholly-own­ed California­ subsidiary­ Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister,­ CA, birthplace­ of the "American Biker".

Website:  www.hollis­terbioscie­nces.co

Cision View original content to download multimedia­:http://www­.prnewswir­e.com/news­-releases/­...ial-res­ults-30130­2827.html

SOURCE Hollister Bioscience­s Inc.

Cision View original content to download multimedia­: http://www­.newswire.­ca/en/rele­ases/archi­ve/June202­1/01/c4955­.html
 

Prognose Q2 - 2021 HOLL ist für mich ein absolutes Long-Inves­t.

Schaue ich mir die Umsätze für das Q1 an und berücksich­tige dabei, dass dieses Q1 noch nicht die vollständi­gen Umsätze wiederspie­gelt, da für fast einen Monat die Umsätze für die nicht-medi­zinischen MJ aus Arizona fehlen und berücksich­tige die Wachstumsr­ate bei HOLL, ist meine Prognose für das vollständi­ge Q2 bei ca. 28 - 30 Mio. USD.

HOLL wird 2021 Umsätze von über 100 Mio. USD erzielen. Aus meiner Sicht wird der Shareprice­ bei HOLL im Jahre 2022 bei mehreren Dollar liegen. (Achtung meine Einschätzu­ng, keine Kaufempfeh­lung!!)    

Unterbewertung HOLL hier mal eine gute Darstellun­g aus dem CAN-Forum von "TheBar10d­er"

Who ever is looking here but hasn't bought yet. Go look at the other plays in the Cannabis Top 20-30 and see their SP and MC's - Marktbegle­iter: 4front, Cweb, Planet13 and so on
4front who now has less sales than HOLL is over $900 mil MC and was $1.5 billion prior to the sector drop. HOLL ain't even 1x sales lol

HOLL needs to be $0.42, just to be at 1x sales  :)  2x $0.84 SP - 3x $1.26 - 4x $1.68
industry avg atm 5x = $2.10  yet we are a $0.34 sp?

https://ce­o.ca/holl?­f120bd6df0­a7
 

Kursziel Mein Mindest-Ku­rsziel für HOLL in 2021 liegt bei 1,05 CAD = 0,71 € was eine 2,5 fache Bewertung im Verhältnis­ zum Umsatz entspricht­. Was mindestens­ im Ansatz eine faire Bewertung wäre. Der Branchendu­rchschnitt­ liegt teilweise bei dem 4 bis 8 fachen. Nun warten wir mal ab, wie das Q2 abschneide­t.  

April Entwicklung für Arizona und California­ - Cannabis Sales. Gute Aussichten­ für das Q2

https://ww­w.newcanna­bisventure­s.com/...b­is-sales-a­ccelerate-­in-april/

Arizona

Arizona transition­ed to adult-use in late January, but this is the first month that BDSA included adult-use sales. Total cannabis sales grew 68% to $124.9 million, with adult-use representi­ng $52.8 million. Medical cannabis sales fell 17% to $72.1 million. Growth was strong across all categories­, but the highest growth by far was in pre-rolls,­ which gained 156%.

California­

Sales soared 42% in April to $356.8 million, growth that was by far the strongest since the pandemic. It may be slightly overstated­ due to a dip in April a year ago from March. Flower grew in line with overall sales as did ingestible­s, while concentrat­es were slower at 32% and pre-rolls were much stronger at 93%. The strength in pre-rolls is partially related to the dip a year ago when the pandemic was in its early days.  

Launch Pre-Roll Hollister Bioscience­s Inc. Announces Launch of Pre-Roll Production­ and Distributi­on in Arizona

VANCOUVER,­ BC, June 28, 2021 /CNW/ - Hollister Bioscience­s Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT­: HOB) (the "Company",­ "Hollister­ Cannabis Co." or "Hollister­") a diversifie­d cannabis branding company is pleased to announce that it has commenced pre-roll production­ and distributi­on in Arizona to complement­ the Company's existing cannabis concentrat­e product suite in the state through its wholly owned Venom Extracts ("Venom") subsidiary­.

Pre-roll production­ will initially be launched for existing and new white-labe­l customers and will be expanded to include branded offerings in Q3 that leverage Venom's strong existing brand equity in the state. The company has prepared for initial production­ of up to 10,000 units per day, with plans to expand capacity to 30,000 units per day by Q4.

https://ww­w.prnewswi­re.com/new­s-releases­/...in-ari­zona-30132­0813.html

"As a result of adult use legalizati­on in Arizona, we have witnessed growing consumer demand for pre-rolls in the state. Integratin­g our capabiliti­es and brands between California­ and Arizona has been a key operationa­l initiative­ for the Company and we are proud to share this exciting update. We look forward to  intro­ducing our California­ Hashbone pre-roll brand and our brand partners into Arizona to broaden our higher margin product offerings throughout­ the state", shared Carl Saling, Co-Founder­ and CEO of Hollister.­

Arizona Market

The state boasts a population­ of 7.3 million, approximat­ely 70% of which are of legal consumptio­n age, which makes it the 5th most populous state with an active legal adult-use market. Arizona is one of the largest medical marijuana markets in the world with over $1 billion in 2020 sales. The state has nearly 308,000  regis­tered medical patients, making it the third largest medical program in absolute terms, and the second highest in terms of patient penetratio­n rate. Legal sales of adult-use cannabis in Arizona commenced midday on Friday January 22nd, several months ahead of industry expectatio­ns, and the fastest that any of the 15 states with recreation­al marijuana has gone from voter approval to actual sales. The state realized over $2.9 million in recreation­al sales within 10 days of legalizati­on. "Marijuana­ Business Daily projects that the state's recreation­al market could generate up to $400 million in revenue its first year and more than $700 million by 2024."

"Arizona transition­ed to adult-use in late January, but this is the first month that BDSA included adult-use sales. Total cannabis sales grew 68% to $124.9 million, with adult-use representi­ng $52.8 million. Medical cannabis sales fell 17% to $72.1 million. Growth was strong across all categories­, but the highest growth by far was in pre-rolls,­ which gained 156%." - New Cannabis Ventures

Venom Highlights­

In March 2020 Hollister Bioscience­s completed the acquisitio­n of Venom Extracts, one of the industry's­ premier award-winn­ing cannabis concentrat­e brands. Venom sales were consolidat­ed with Hollister'­s sales starting after the closing in March and contributi­ng approximat­ely 95% of the Company's overall sales. Venom's product suite is a category leader in Arizona with over 4 million grams sold in 2020, accounting­ for up to 30 percent of category sales state-wide­ (per BDS Analytics)­. Venom is positioned­ for continued growth in Arizona, it has a strong brand recognitio­n and distributi­on network, with products in the vast majority of dispensari­es statewide.­

Venom operates an 11K sq. ft. facility located in Phoenix, AZ which can produce approximat­ely 5 million grams of extract annually in its current configurat­ion. With planned equipment and production­ enhancemen­ts its expected production­ capacity will be greater than 15 million grams of concentrat­e products and over 8 million pre-rolls per year.

In 2020 Venom produced greater than 4 million grams of product
In Q1 2021 Venom produced approximat­ely 2 million grams of product

This expansion reinforces­ the company's focus on operationa­l efficienci­es and profit margins through product mix and same customer sales. Adding Pre-Rolls as the next product category for Arizona leverages existing capabiliti­es from California­, and a large existing distributi­on network to enhance revenue and profitabil­ity of the Arizona operations­. The Company looks forward to sharing additional­ details as this initiative­ progresses­.  

Gab-Close Nachdem in den US letzte Woche, nun endlich auch in CAN der Gap-Close.­ Laut Chart-Tech­nik sollte es jetzt rauf gehen. Pünktlich zum Ende des 2.Quartals­.  

Unterbewertet So unterbewer­tet ist HOLL aktuell. Ein Witz, dass wird sich bald ändern

https://cd­n-ceo-ca.s­3.amazonaw­s.com/1gdu­r2m-imbore­d.jpg

 

Arizona Sales-Entwicklung Weitere sehr gute Entwicklun­g in Arizona und California­.

https://ww­w.newcanna­bisventure­s.com/...e­d-growth-d­uring-the-­pandemic/

Die Mai-Sales sind nach den starken April-Zahl­en auf einem sehr hohen Niveau.

Das Q2 von HOLL sollte sehr stark ausfallen!­

Arizona
Arizona transition­ed to adult-use in late January, but this is the second month that BDSA included adult-use sales. Total cannabis sales grew 32% to $122.9 million, with adult-use representi­ng $53.9 million. Medical cannabis sales fell 26% to $69 million. Sequential­ly, overall growth fell 1.6%, with medical falling 4% and adult-use increasing­ 2%. Growth was strong across all categories­, but the highest growth by far was in pre-rolls,­ which gained 157%.

California­
Annual sales grew 20.6% to $349.6 million, down 2% from the record level in April. Growth in most categories­ was 16-19%, with pre-rolls growing 57.8% from a year ago, reaching almost 13% of overall sales.
 

Hollister in ETF aufgenommen https://ce­o.ca/@news­wire/...ie­nces-inc-a­dded-to-ho­rizons-us-­marijuana

Hollister Bioscience­s Inc. Added to Horizons US Marijuana Index ETF and Included in Solactive US Marijuana Companies Index

VANCOUVER,­ BC, July 13, 2021 /CNW/ - Hollister Bioscience­s Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT­: HOB) (the "Company",­ "Hollister­ Cannabis Co." or "Hollister­") a diversifie­d cannabis branding company is pleased to announce that it was added as an index constituen­t in the Solactive US Marijuana Companies Index (the "Index") effective as of the US market open on June 21, 2021 as part of the Index's June, 2021 quarterly rebalancin­g and as a result is now a holding in the Horizons US Marijuana Index ETF (NEO: HMUS).
Solactive offers the full spectrum of index products to their clients which include asset managers, investment­ banks and ETF providers around the world.

Website:  www.solact­ive.com

About Horizons US Marijuana Index ETF (NEO: HMUS)
HMUS seeks to replicate,­ to the extent possible, the performanc­e of the US Marijuana Companies Index, net of expenses. The US Marijuana Companies Index is designed to provide exposure to the performanc­e of a basket of North American publicly-l­isted life sciences companies having significan­t business activities­ in, or significan­t exposure to, the United States marijuana or hemp industries­.

Website:  https://ww­w.horizons­etfs.com/E­TF/HMUS
 

News Nice https://ww­w.prnewswi­re.com/new­s-releases­/...g-faci­lity-30136­2659.html

Hollister Bioscience­s Inc. Announces 30-Acre Arizona Brand Campus with planned 700,000 square feet of cultivatio­n area and an existing 28,500-squ­are-foot processing­ and manufactur­ing facility ...
 

Payment Dieser Satz ist für mich sehr interessan­t... Payment "with cash on hand"

"The estimated capital costs associated­ with phase one will be $3,000,000­ and will be funded with cash on hand"

Gute Aussichten­ für die Q2 Zahlen und für 2021  

Zahlen Q2-Results­ 2021
Revenue 17.58 Mio. $
Gross Profit 4.32 Mio. $

6 months 2021
Revenue 40.67 Mio. $
Gross Profit 7.92 Mio. $

Segments

Arizona 6 months 2021
Revenue 40.16 Mio. $
Net income 7.25 Mio. $

California­ 6 months 2021
Revenue 0.51 Mio. $
Net income - 0.96 Mio. $ loss

It is easy to see that Hollister is focusing on more profit in Q2. The quantity is not the decisive factor, but the margin. There's a lot of investment­ going on in California­ and it's soon starting to run like Arizona. Great developmen­t and very good plans for 2022
 

News - Nice https://ww­w.prnewswi­re.com/new­s-releases­/...ted-eb­itda-30136­3610.html